A beginner’s guide to immunotherapy
Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
To book, contact: email@example.com or call: 020 7808 2922
View an outline of the programme